Company intelligence / Profile preview

Triaxial Pharmaceuticals

Cranford, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

Triax Pharmaceuticals specialized in branded dermatology products, including minocycline (Minocin Kits), tretinoin (Tretin-X Kits), and fluorouracil-based therapies. All assets were acquired by PreCision Dermatology in 2012, with most products now legacy or discontinued[1][3][6].

Therapeutic areas: DermatologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Triaxial Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Triaxial Pharmaceuticals.

Explore the full profile